Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5776
CALL
ICICI Bank
IBN
$105B
| $1.7M | ﹤0.01% |
95,800
+35,900
| +60% | +$671K |
|
|
SAGE
5777
CALL
DELISTED
Sage Therapeutics
SAGE
| $1.7M | ﹤0.01% |
52,600
-29,800
| -36% | -$999K |
|
|
BCTX
5778
CALL
Briacell Therapeutics
BCTX
$29.5M
| $1.7M | ﹤0.01% |
1,961
-1,958
| -50% | -$1.93M |
|
5779
AerCap
AER
$23.6B
| $1.7M | ﹤0.01% |
41,450
+24,301
| +142% | +$1.13M |
|
5780
FS Bancorp
FSBW
$319M
| $1.7M | ﹤0.01% |
+59,108
| New | +$1.75M |
|
5781
PubMatic
PUBM
$787M
| $1.7M | ﹤0.01% |
106,747
-134,408
| -56% | -$2.88M |
|
5782
DXP Enterprises
DXPE
$3.1B
| $1.7M | ﹤0.01% |
+55,312
| New | +$1.52M |
|
5783
GeoPark
GPRK
$622M
| $1.7M | ﹤0.01% |
131,156
+60,772
| +86% | +$950K |
|
5784
SiTime
SITM
$22.5B
| $1.7M | ﹤0.01% |
10,398
-7,231
| -41% | -$1.37M |
|
5785
PUT
Carlisle Companies
CSL
$14.3B
| $1.69M | ﹤0.01% |
+7,100
| New | +$1.77M |
|
5786
CALL
Tetra Tech
TTEK
$9.17B
| $1.69M | ﹤0.01% |
62,000
-25,500
| -29% | -$699K |
|
|
CVAC
5787
DELISTED
CureVac
CVAC
| $1.69M | ﹤0.01% |
124,330
-172,270
| -58% | -$2.85M |
|
5788
iShares S&P India Nifty 50 Index Fund
INDY
$559M
| $1.69M | ﹤0.01% |
41,238
+6,427
| +18% | +$280K |
|
5789
CALL
Vroom Inc
VRM
$50.6M
| $1.69M | ﹤0.01% |
16,923
+8,250
| +95% | +$1.04M |
|
|
VRAY
5790
DELISTED
ViewRay, Inc.
VRAY
| $1.69M | ﹤0.01% |
636,805
-381,531
| -37% | -$1.15M |
|
5791
Sprout Social
SPT
$579M
| $1.69M | ﹤0.01% |
29,059
-30,471
| -51% | -$1.77M |
|
|
ACACU
5792
DELISTED
Acri Capital Acquisition Corp Unit
ACACU
| $1.69M | ﹤0.01% |
+169,073
| New | +$1.69M |
|
5793
PUT
Cavco Industries
CVCO
$4.61B
| $1.69M | ﹤0.01% |
+8,600
| New | +$1.92M |
|
5794
Seacoast Banking Corp of Florida
SBCF
$3.47B
| $1.69M | ﹤0.01% |
51,007
+24,170
| +90% | +$808K |
|
5795
BrightView Holdings
BV
$1.06B
| $1.69M | ﹤0.01% |
140,379
-1,218
| -0.9% | -$15.3K |
|
5796
First Trust US Equity Opportunities ETF
FPX
$1.59B
| $1.69M | ﹤0.01% |
20,514
+8,722
| +74% | +$812K |
|
|
DCH
5797
PUT
Dauch Corp
DCH
$1.62B
| $1.68M | ﹤0.01% |
223,600
-64,200
| -22% | -$483K |
|
5798
Riot Platforms
RIOT
$7.52B
| $1.68M | ﹤0.01% |
+401,966
| New | +$3.73M |
|
5799
iShares MSCI Saudi Arabia ETF
KSA
$627M
| $1.68M | ﹤0.01% |
40,657
+36,050
| +783% | +$1.68M |
|
|
VLDR
5800
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $1.68M | ﹤0.01% |
1,761,763
+973,761
| +124% | +$1.68M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.